Augmentin and Enulose drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Augmentin (amoxicillin; clavulanate potassium) and Enulose (lactulose). Common drug interactions include musculoskeletal pain among females and drug intolerance among males.

The phase IV clinical study analyzes what interactions people have when they take Augmentin and Enulose. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Augmentin?

Augmentin has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 42,620 Augmentin users. Check the latest studies of Augmentin.

What is Enulose?

Enulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 711 Enulose users. Check the latest studies of Enulose.



On Jul, 08, 2026

18 people who take Augmentin and Enulose together, and have interactions are studied.

Augmentin and Enulose drug interactions.

What are the common drug interactions of Augmentin and Enulose, by gender? *:

female:

  1. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  2. Non-cardiac chest pain
  3. Oedema peripheral (superficial swelling)
  4. Abdominal tenderness
  5. Anaemia (lack of blood)
  6. Anaemia macrocytic (a macrocytic class of anaemia)
  7. Anal sphincter atony (anal muscles are weak and cannot ensure an efficient sealing, this is called a sphincter atony)
  8. Antinuclear antibody positive
  9. Anxiety
  10. Aphasia (damage to the parts of the brain that control language)

male:

  1. Drug intolerance (drug sensitivity)
  2. Agitation (state of anxiety or nervous excitement)
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  4. Tachypnoea (a condition of rapid breathing over 20 per minute)
  5. Abdominal pain
  6. Anaemia (lack of blood)
  7. Aspartate aminotransferase increased
  8. Blood bilirubin increased
  9. Cardiac arrest
  10. Chronic hepatic failure (long lasting liver failure)

What are the common drug interactions of Augmentin and Enulose, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Agitation (state of anxiety or nervous excitement)
  2. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  3. Drug intolerance (drug sensitivity)
  4. Fall
  5. Infusion related reaction
  6. Lymphadenopathy (disease or enlargement of lymph nodes)
  7. Pyrexia (fever)
  8. Rash
  9. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  10. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Memory impairment
  3. Anaemia (lack of blood)
  4. Ascites (accumulation of fluid in the abdominal cavity)
  5. Aspartate aminotransferase increased
  6. Blood bilirubin increased
  7. Cardiac arrest
  8. Chronic hepatic failure (long lasting liver failure)
  9. Cirrhosis alcoholic (chronic disease of the liver marked by degeneration of cells, inflammation, and fibrous thickening of tissue caused by alcoholism)
  10. Coagulopathy (blood's ability to clot is impaired)

50-59:

  1. Injury
  2. Insomnia (sleeplessness)
  3. Interstitial lung disease
  4. Large intestinal ulcer
  5. Light chain analysis increased
  6. Localised infection (infection at the single location)
  7. Monoclonal gammopathy
  8. Mood altered (changes in mood)
  9. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  10. Nausea (feeling of having an urge to vomit)

60+:

  1. Confusional state
  2. Death
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Balance disorder
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Cough
  10. Dizziness

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 27.78%
  2. Immunodeficiency Common Variable: 4 people, 22.22%
  3. Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 16.67%
  4. Pain: 3 people, 16.67%
  5. Nausea (feeling of having an urge to vomit): 2 people, 11.11%
  6. Indigestion: 2 people, 11.11%
  7. Cough: 2 people, 11.11%
  8. Nausea And Vomiting: 2 people, 11.11%
  9. High Blood Pressure: 2 people, 11.11%
  10. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin and Enulose?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Augmentin and Enulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Augmentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Enulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Augmentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Enulose and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium and lactulose (the active ingredients of Augmentin and Enulose, respectively), and Augmentin and Enulose (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: